جست‌وجوی استاد و پژوهشگر

Gökçenur Karakelleoğluمشاهده پروفایل

مدرس

• Obstetrics
• Gynecology
• Prenatal Diagnosis
• +۴ مورد دیگر

Dr. Gökçenur Karakelleoğlu serves as a Lecturer in the Department of Obstetrics and Gynecology at Istanbul Okan University Faculty of Medicine, specializing in women's sexual health and advanced surgical techniques including laparoscopic and robotic procedures in gynecologic oncology. Her clinical practice integrates evidence-based approaches to maternal-fetal medicine and complex gynecological conditions. Her academic foundation includes: Medical Degree: Istanbul University Faculty of Medicine (2000-2006) Specialization: Bilim University Department of Obstetrics and Gynecology Research focuses on prenatal diagnostic innovation, fetal abnormality management, and gynecological pathologies including endometriosis and scar-related complications. Her work emphasizes improving maternal outcomes through advanced imaging techniques and surgical interventions, with particular attention to gestational diabetes prediction and fetal growth restriction indicators. Analysis of her 40+ publications reveals consistent contributions to obstetric screening methodology, especially in predicting small-for-gestational-age infants through biochemical markers (PAPP-A, hCG, TSH) and ultrasound parameters. Recent work demonstrates expertise in rare condition management including cesarean scar pregnancies and vaginal sarcomas. Professional development includes active membership in the Turkish Gynecology and Obstetrics Association and specialized training in: Laparoscopic suture techniques (2015) Hysteroscopy (2015) Fetal heart screening (2009) Neonatal resuscitation (2010)

Jovana Jovanović Marićمشاهده پروفایل

پژوهشگر

• Ecotoxicology
• Genotoxicology
• Environmental Monitoring
• +۲ مورد دیگر

Dr. Jovana Jovanović Marić is a Researcher at the Department of Hydroecology and Water Protection within the Institute for Biological Research "Siniša Stanković" , affiliated with the University of Belgrade . She completed her Ph.D. in Biology (Microbiology module) in 2021, preceded by M.Sc. and B.Sc. degrees in microbiology from the same university. Key research areas: Ecotoxicology , Genotoxicology , and Environmental Monitoring Recipient of prestigious awards: 2021 Milena Dalmacija Foundation Prize for best doctoral thesis in environmental protection and 2018-2021 Ministry of Education Ph.D. Fellowship Recent publications focus on microplastic pollution , chemical-induced DNA damage , and environmental monitoring methodologies across the Danube River Basin and Adriatic coastal waters. She actively participates in international initiatives like the Joint Danube Survey and STRIMHealth project , with fieldwork in Slovenia, Montenegro, and Portugal. Professional affiliations include the Serbian Biological Society , Serbian Society for Water Protection , and European Environmental Mutagen Society .

Jennifer E. Phillips-Creminsمشاهده پروفایل

دانشیار

• 3D Genome Organization
• Chromatin Biology
• Neurogenetics
• +۵ مورد دیگر

Jennifer E. Phillips-Cremins, Ph.D. , is an Associate Professor of Genetics and Bioengineering at the University of Pennsylvania, where she leads the Laboratory of Chromatin and Spatial Neurobiology. A member of the Penn Epigenetics Institute and NIH 4D Nucleome Consortium, her research investigates how three-dimensional chromatin organization governs neural specification, synaptic plasticity, and disease pathogenesis. Her lab integrates 3D genome mapping, single-cell imaging, and computational tools to dissect chromatin-synapse communication in Alzheimer's disease, fragile X syndrome, and schizophrenia. Education : B.S. in Chemical Engineering (Clarkson University, 1999), Ph.D. in Biomedical Engineering (Georgia Tech, 2007) Postdoctoral Training : University of Massachusetts (Dekker Lab) and Emory University (Corces Lab, 2008-2013) Her lab has developed groundbreaking technologies including LADL for optogenetic chromatin control, FISHnet for single-cell spatial genomics, and MASTR-seq for repeat expansion analysis. Key discoveries demonstrate that cohesin-mediated loops regulate replication origins and synaptic gene expression, while BREACHes link repeat instability to neurodevelopmental defects. Scientific Recognition : NIH Pioneer Award (2021) NSF CAREER Award (2020) Chan-Zuckerberg Neurodegenerative Disease Awardee (2020) New York Stem Cell Foundation Robertson Investigator (2015-2020) Mentorship : Creator of the SEEDs program for undergraduate/post-baccalaureate training, with 100% of alumni pursuing advanced scientific degrees. Her lab currently trains 3 SEEDs scholars and advises graduate students in Cell and Molecular Biology, Neuroscience, and Bioengineering programs.

Priyanka Baloniمشاهده پروفایل

استادیار

• Systems Biology
• Metabolomics
• Neurodegenerative Diseases
• +۹ مورد دیگر

Priyanka Baloni serves as an Assistant Professor in Purdue University's School of Health Sciences and is a member of the Purdue Institute for Integrative Neuroscience. Her research leverages computational systems biology to investigate metabolic dysregulation in neurodegenerative diseases, cancer, and aging through multi-omics integration. Education: PhD, Indian Institute of Science, 2017 Research Focus: Dr. Baloni specializes in identifying metabolic signatures across neurodegenerative conditions (particularly Alzheimer's disease), preterm birth, and infectious diseases using genome-scale metabolic modeling and network analysis. Her lab develops computational frameworks for multi-omics data (genomics, transcriptomics, metabolomics, proteomics) to study gene-environment interactions, with emphasis on neurotoxic exposures like PFAS. Key contributions include human brain region-specific metabolic networks and identification of bile acids/sphingolipids as Alzheimer's therapeutic targets through NIH AMP-AD collaborations. Publication Trends: Recent work (2023-2025) reveals consistent focus on Alzheimer's mechanisms (APOE interactions, mitochondrial dysfunction), environmental toxicology (PFAS impacts on lipid metabolism), and multi-omics analysis of aging/preterm birth. Her publications frequently emerge from large consortia, demonstrating translational applications of systems biology for biomarker discovery and therapeutic targeting. Scientific Recognition: Laxmi Baxi Award, Society for Reproductive Investigation (2020) CSIR Senior Research Fellowship (2012-2015) UGC Post-Graduate Merit Scholarship (2007-2009) Research Leadership: As Co-Investigator on four NIH grants—including projects on placental development (NICHD R01 HD091527), Alzheimer's target prioritization (NIA U01AG061359), sex differences in AD (NIA RF1AG059093), and microbiome modeling (NIDDK 1R01DK133468)—she directs computational efforts across multi-institutional teams. She actively mentors undergraduate and graduate students in computational toxicology and systems biomedicine. Collaborative Infrastructure: The Baloni Lab develops open-source tools for metabolic network analysis while contributing to Purdue's emerging computational toxicology program. Her work integrates with the Institute for Systems Biology and NIH consortia to address complex health challenges through interdisciplinary data science approaches.

• Dermatology
• Dermatopathology
• Mohs Micrographic Surgery
• +۳ مورد دیگر

Keith L. Duffy, MD is an Associate Professor (Clinical) in the Department of Dermatology at the University of Utah, where he specializes in Mohs micrographic surgery, melanoma and cutaneous oncology, and dermatopathology. He practices clinically at the Huntsman Cancer Institute, Midvalley Health Center, University of Utah Hospital, and the Salt Lake City Veterans Administration Medical Center. Education & Training: MD – SUNY Upstate Medical University Internship – Internal Medicine, Tufts University School of Medicine / St. Elizabeth’s Medical Center Residency & Chief Residency – Dermatology, University of Utah Fellowship – Dermatopathology, University of Chicago Fellowship – Mohs Micrographic Surgery & Cutaneous Oncology, University of British Columbia Fellowship – Pathology, SUNY Upstate Medical University BS – Biology, Boston College Research Interests: Dr. Duffy’s scholarly work centers on the histopathology and surgical management of melanoma and non-melanoma skin cancers, with particular attention to Mohs surgery outcomes, opioid prescribing practices, and rare cutaneous neoplasms. His investigations span molecular drivers of melanoma metastasis, recurrence patterns in special-site nevi, and clinicopathologic correlations in challenging dermatologic entities. Publication Trends: Across more than 40 peer-reviewed contributions, Dr. Duffy has concentrated on three dominant themes: (1) optimizing surgical margins and post-operative care in Mohs and melanoma surgery; (2) delineating histopathologic features that predict biologic behavior in melanocytic and fibrohistiocytic lesions; and (3) describing novel or rare cutaneous presentations—from carcinosarcoma to drug-induced eruptions—to expand diagnostic acumen. Scientific Awards & Recognition: Board Certified – American Board of Dermatology (Dermatology & Dermatopathology) Consistently high patient-experience ratings (4.9/5 average over 474 reviews) Grants & Advising: While specific grant numbers are not detailed, Dr. Duffy’s extensive publication record and editorial roles imply ongoing extramural or intramural funding. No formal roster of graduate students was provided; he trains residents and fellows in Mohs surgery and dermatopathology. Laboratory & Clinical Teams: Dr. Duffy works within the multidisciplinary cutaneous oncology teams at the Huntsman Cancer Institute and University of Utah Department of Dermatology, collaborating with dermatopathologists, medical oncologists, and reconstructive surgeons to deliver comprehensive care for high-risk skin cancer patients.

• Causal Inference
• Machine Learning
• High Dimensional Data Analysis
• +۳ مورد دیگر

Jincheng Shen is an Assistant Professor in the Department of Population Health Sciences at the University of Utah, with adjunct roles in the Departments of Family & Preventive Medicine and Internal Medicine. He completed his PhD in Biostatistics at the University of Michigan, Ann Arbor, postdoctoral training at Harvard T.H. Chan School of Public Health, and holds a BS and MS in Computer Science from Tsinghua University. His methodological research focuses on causal inference , machine learning , high-dimensional data analysis , and statistical genetics . Applications span cancer studies, cardiovascular health, opioid use disorder, and chronic disease management. He actively collaborates with clinicians, biologists, and epidemiologists, particularly in analyzing longitudinal data from trials like SPRINT and AASK. Recent publications (2024–2025) highlight his work in optimizing dynamic treatment regimes for diabetes, cardiovascular disease, and cancer, using machine learning and epigenetic biomarkers . He also contributes to school-based interventions for skin cancer prevention and community pharmacy protocols for opioid misuse. Collaborations include large-scale studies on DNA methylation , aging , and environmental exposures , with applications in COPD, cardiovascular outcomes, and cancer risk prediction. His interdisciplinary approach bridges statistical methodology with real-world clinical and public health challenges.

• Pulmonary Medicine
• Interventional Pulmonology
• Lung Cancer
• +۴ مورد دیگر

Sikandar A. Ansari is a Clinical Associate Professor in the Department of Internal Medicine , affiliated with the Huntsman Cancer Center . He specializes in Pulmonary and Critical Care Medicine , with a focus on Interventional Pulmonology and Lung Cancer . Dr. Ansari holds certifications from the American Board of Internal Medicine in both Critical Care Medicine and Pulmonary Disease , and is a member of the American Association for Bronchology and Interventional Pulmonology .

Elizabeth Rebecca Hauserمشاهده پروفایل

استاد

• Statistical Genetics
• Biostatistics
• Genetic Epidemiology
• +۱۰ مورد دیگر

Elizabeth Rebecca Hauser is a Professor of Biostatistics & Bioinformatics at Duke University and Member of the Duke Molecular Physiology Institute, leading research in statistical genetics and biostatistics with focus on gene-environment interactions in human diseases. Her work bridges computational methods with biomedical applications across multiple disease domains. Her educational qualifications include: Ph.D. in Biostatistics, University of Michigan, Ann Arbor (1998) M.S. in Biostatistics, University of Michigan, Ann Arbor (1992) M.H.S., Johns Hopkins University (1985) Dr. Hauser's research integrates statistical genetics, genetic epidemiology, and biostatistics to investigate cardiovascular disease, Gulf War Illness, colon cancer, suicide, exercise behavior, aging, and kidney disease. She develops methods for gene mapping and genetic association studies while emphasizing environmental interactions, with recent work leveraging large veteran cohorts like the Million Veteran Program. Her approach combines computational biology with clinical applications to advance personalized medicine. Analysis of her 2024-2025 publications reveals strong thematic focus on veteran health outcomes, particularly Gulf War Illness multimorbidity patterns, cardiovascular genetics through lipoprotein analysis, colorectal cancer risk recalibration, and suicide prevention. These studies consistently employ advanced statistical modeling of genetic and 'omics data within large cohorts, demonstrating methodological innovation in electronic health record analysis and risk prediction. Dr. Hauser directs multiple major grants including: Duke University Program in Environmental Health (NIEHS, 2019-2029) The Effect of Exercise on T Cell Aging in Rheumatoid Arthritis (NIA, 2024-2029) Accelerated Aging in Gulf War Illness (DoD, 2023-2027) Skeletal Muscle Molecular Drug Targets for Exercise-induced Cardiometabolic Health (NHLBI, 2021-2026) Duke CARiNG-StARR Residency Program (NIH, 2020-2025) She co-leads research teams within the Duke Center for Statistical Genetics and Genomics and Duke Molecular Physiology Institute, fostering collaborative projects that integrate statistical methodology development with biomedical discovery across cardiovascular, neurological, and cancer research domains.

• Nutrition Science
• Public Health Nutrition
• Chemosensory Perception
• +۳ مورد دیگر

Valerie B. Duffy is a Professor and Graduate Program Director at the University of Connecticut's Department of Allied Health Sciences. Her research focuses on chemosensory variation in humans and its impact on food perception and intake, alongside community-based interventions to improve children's nutrition and physical activity, particularly for economically disadvantaged populations. Education: Human Nutrition (BS) from Cornell University, Nutrition Science (MS) and Registered Dietitian credential from Rush University, Psychophysics of Taste from University of Connecticut, and postdoctoral training at Yale University School of Medicine. Her work spans sensory science, public health nutrition, and digital health interventions. Key areas include taste/smell disorders, food environment mapping, and technology-enabled nutrition education. Recent research emphasizes food swamps, GIS-based resource mapping, and digital food literacy tools. She mentors undergraduate and graduate students in community nutrition projects and has received institutional recognition for excellence in teaching, research, and service.

• Pharmacology
• Toxicology
• Drug Safety
• +۶ مورد دیگر

Professor Christopher Goldring serves as Deputy Executive Dean of the Institute for Systems, Molecular and Integrative Biology at the University of Liverpool's Department of Pharmacology and Therapeutics. He co-directs the Human Liver Research Facility and the Joint Centre for Pharmacology and Therapeutics with XJTLU in Suzhou, China, while holding advisory roles with the MHRA Herbal Medicines Advisory Committee and MRC DiscoveryMedicineNorth doctoral training program. Goldring's research centers on translational drug safety , focusing on developing humanised biologically-relevant models for predicting adverse drug reactions. Key initiatives include: Leading UKRI's 3Dbionet project to enhance 3D in vitro liver models Establishing pipelines for human primary liver cells (>380 samples since 2011) Developing industry-adopted roadmaps for pharmaceutical safety assessment Creating precision-cut tissue slice models for drug metabolism studies Investigating cholangiocarcinoma genomics and targeted therapies Analysis of his 2020-2025 publications reveals three dominant trends: biomarker validation for drug-induced liver injury (DILI), physiological refinement of complex in vitro models (organoids, 3D cultures), and translational oncology focusing on biliary tract cancers. His work bridges academic research with pharmaceutical industry needs through twelve industry partnerships. Recognition includes: Fellow of the British Pharmacological Society Goldring supervises PhD research on stem cell-derived hepatocyte models, DILI biomarkers, and NRF2-mediated immune responses while securing major funding including: TransBioLine consortium (EU Commission, 2019-2025): $22M for translational biomarker development AMMF Charity projects (2017-2026): Cholangiocarcinoma immunosuppression studies NW Cancer Research (2023-2027): Uveal melanoma metastasis modeling MRC/BBSRC grants: Liver model reproducibility and physiological relevance He co-directs the Centre for Drug Safety Science and Human Liver Research Facility, leading teams that include pharmaceutical partners (Janssen, Pfizer, Merck) and international academic collaborators to establish standards for preclinical safety assessment.

• Human Genetics
• Genetic Mapping
• Inherited Disorders
• +۷ مورد دیگر

Professor Tayfun Özçelik serves as Dean of the Faculty of Science at Bilkent University, where he chairs the Department of Molecular Biology and Genetics. A distinguished human geneticist, his career spans foundational work in identifying genes for inherited disorders and pioneering DNA identification in Turkish judiciary systems. He has led diagnostic genetics laboratories at both Istanbul and Bilkent Universities. 1986: MD, İstanbul University Medical School Postdoctoral: Physiology (Munich), Human Genetics (Yale), Howard Hughes Medical Institute (Stanford) His research focuses on molecular characterization of inherited disorders including Prader-Willi syndrome, Charcot-Marie-Tooth disease, and Parkinson’s. Current projects examine complex phenotypes like obesity and polycystic ovarian syndrome through genetic mapping and reverse phenotyping in consanguineous families. Recent work explores type I IFN immunity in severe COVID-19 cases. Key scientific contributions include discoveries of SNRPN for PWS, PMP22 for CMT1A, and HTRA2 for Parkinson’s. His lab also identified genes VLDLR , WDR81 , and ATP8A2 linked to cerebellar hypoplasia. Scientific Awards TÜBİTAK Young Investigator Award (1996) Bayındır Medical Award (2006) TÜBİTAK Science Award (2012) Dr. Özçelik has advised numerous graduate students and collaborates internationally, particularly with Rockefeller University. His work extends to X chromosome inactivation patterns in autoimmune diseases and establishing genomic medicine infrastructure in Turkey.

• Endocytosis
• Neurons
• Membrane Trafficking
• +۲ مورد دیگر

Peter McPherson, PhD, is a Professor in the Department of Neurology and Neurosurgery at McGill University 's Faculty of Medicine and Health Sciences . He is based at the Montreal Neurological Institute (MNI), where his laboratory is part of the MNI’s Neurodegenerative Disease Research Group. University: McGill University School: Faculty of Medicine and Health Sciences Department: Department of Neurology and Neurosurgery Lab Affiliation: Brain Tumour Research Centre, Montreal Neurological Institute Research Focus : Dr. McPherson’s lab investigates molecular mechanisms regulating endosomal membrane trafficking and its role in neurological disorders. Key areas include: Clathrin-coated pit/vesicle dynamics in neurons Links between trafficking defects and neurodevelopmental/neurodegenerative diseases (e.g., Parkinson’s, ALS, ARSACS, glioblastoma) Antibody validation via YCharOS initiative with industry partners Structural and functional characterization of trafficking proteins Recent Trends : Publications emphasize antibody validation protocols (2024-2025), α-synuclein pathology in Parkinson’s, and DENND5A/RAB35 mutations in epileptic encephalopathy. Collaborative work spans lysosomal positioning , autophagy regulation , and C9orf72/SMCR8 complexes in inflammation. Labs & Teams : The lab operates at the Montreal Neurological Institute in the Brain Tumour Research Centre , collaborating with 14 antibody manufacturers and knockout cell line providers through YCharOS. The team uses biochemical, molecular, structural, and cellular approaches to study endo/lysosomal pathways.

Michael Thompsonمشاهده پروفایل

استادیار

• Health Services Research
• Cardiac Surgery
• Health Policy
• +۶ مورد دیگر

Michael Thompson is an Assistant Professor at the University of Michigan with multidisciplinary appointments in the Department of Cardiac Surgery at the Medical School, and Departments of Health Management and Policy and Epidemiology at the School of Public Health. He serves as Co-Director of the Michigan Value Collaborative and Director of Analytic Strategy at the Center for Healthcare Outcomes and Policy. PhD in Epidemiology (Michigan State University, 2015) MPH in Public Health (University of Michigan, 2011) BS in Biomedical Sciences (Michigan State University, 2009) Dr. Thompson's research focuses on health services evaluation, particularly examining: Provider performance measurement and quality improvement in cardiac surgery Telemedicine implementation and impact Cardiac rehabilitation programs and outcomes Health policy effects on Medicare populations Health disparities in cardiovascular care Payment system reforms and financial incentives His work combines rigorous quantitative analysis with policy translation, leading AHRQ-funded projects on cardiac rehabilitation determinants and telehealth impact analysis. Recent publications demonstrate his leadership in evaluating: Value-based payment models in healthcare Statewide quality improvement collaboratives Device-related surgical outcomes Post-discharge care pathways Health equity interventions Telemedicine utilization trends Scientific Honors: Young Investigator Research Grant, American Heart Association (2014) AHRQ/HCUP Outstanding Article of the Year Award (2017) Dr. Thompson contributes to major professional organizations including the Institute for Healthcare Policy and Innovation, American Heart Association/American Stroke Association Council on Quality of Care, AcademyHealth, and The Society of Thoracic Surgeons. His research spans clinical and policy journals such as Circulation: Cardiovascular Quality and Outcomes , Health Affairs , and Critical Care Medicine .

Seung Yeoun Leeمشاهده پروفایل

استاد

• Survival Analysis
• Gene-Gene Interactions
• Clinical Trials
• +۳ مورد دیگر

Seung Yeoun Lee is a Professor in the Department of Mathematics and Statistics at Sejong University, where he has been faculty since 1993. His research focuses on applying advanced statistical methodologies to biomedical problems, particularly in cancer research and survival analysis. He serves as Vice President of the Korean Statistical Society and previously served as President of the International Biometric Society Korean Region from 2016-2017. Education: Ph.D. in Statistics, University of Michigan (1990) M.S. in Statistics, Seoul National University (1986) B.S. in Statistics, Seoul National University (1984) Professor Lee's research primarily centers on survival analysis methodologies and their applications in biomedical research, with a particular emphasis on gene-gene interactions and clinical trial statistics. He has pioneered innovative approaches including the Cox model based unified MDR method for gene-gene interaction analysis for survival phenotypes. His work bridges mathematical statistics with practical medical applications, particularly in pancreatic cancer diagnostics and prognostics. The fingerprint analysis of his work shows strong connections to Dimensionality Reduction (94%), Pancreas Cancer research (89%), and Gene Interaction studies (64%). His recent publications demonstrate a clear trend toward interdisciplinary research combining traditional biostatistical methods with modern machine learning approaches. Many papers focus on survival prediction models, dimensionality reduction techniques, and applications to pancreatic cancer research. His work consistently involves international collaborations across statistics, oncology, and computational biology fields, reflecting the highly interdisciplinary nature of modern biomedical research. Professor Lee has made substantial contributions to biostatistical methodology with an h-index of 22, reflecting the impact of his 89 research publications. His work contributes to UN Sustainable Development Goals related to good health and well-being through advanced statistical approaches to medical research. His research group focuses on developing and applying advanced statistical methods to solve complex biomedical problems, with particular emphasis on cancer research and survival analysis. The interdisciplinary nature of his work suggests extensive collaborations with medical researchers, oncologists, and computational biologists across multiple institutions.

Sophia K. Smithمشاهده پروفایل

دانشیار

• Behavioral and Mobile Health (mHealth) Interventions
• Comparative Effectiveness Research
• Cancer Survivorship Needs
• +۳ مورد دیگر

Sophia K. Smith, PhD, MSW is an Associate Professor at Duke University School of Nursing and a senior scientist in the Duke Clinical Research Institute's Cancer Care Research Program (DCCRP) and Center of Learning Health Care (CLHC). Her work pioneers mHealth and psychosocial solutions to improve cancer survivorship outcomes, with emphasis on non-Hodgkin lymphoma survivors' quality of life and PTSD. Her educational background includes: PhD and MSW from University of North Carolina School of Social Work BS in Business Administration (Information Systems) from State University of New York at Albany Dr. Smith's research integrates behavioral mHealth interventions, comparative effectiveness analysis, and patient-centered outcomes to address cancer care quality gaps. She focuses on survivorship needs across rural/non-rural populations and develops evidence-based supportive care frameworks through program evaluation methodologies. Her 2024-2025 publications reveal three dominant trends: (1) Leadership in NCCN Survivorship Guidelines updates addressing PTSD and palliative care disparities; (2) Biomarker-driven approaches to infection response and cardiac complications in cancer patients; (3) Rigorous examination of racial inequities in hematologic cancer palliative care access. Scientific Awards: No awards documented in provided materials As faculty in Duke's MSN and DNP programs, Dr. Smith mentors nursing students while leading grant-funded initiatives through DCCRP and CLHC. Her research ecosystem leverages integrated data systems for patient-reported outcomes, clinical trial design, and policy studies to advance survivorship care models. She operates within Duke's Oncology Nursing Center of Excellence and collaborates with multidisciplinary teams across DCCRP to develop technology-enhanced symptom monitoring tools and implement evidence-based supportive care services.